These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 17327332

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Two-dimensional fluorescence difference gel electrophoresis analysis of the urine proteome in human diabetic nephropathy.
    Sharma K, Lee S, Han S, Lee S, Francos B, McCue P, Wassell R, Shaw MA, RamachandraRao SP.
    Proteomics; 2005 Jul; 5(10):2648-55. PubMed ID: 15984045
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Proteome analysis of serum from type 2 diabetics with nephropathy.
    Kim HJ, Cho EH, Yoo JH, Kim PK, Shin JS, Kim MR, Kim CW.
    J Proteome Res; 2007 Feb; 6(2):735-43. PubMed ID: 17269729
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Proteomic analysis for the assessment of diabetic renal damage in humans.
    Mischak H, Kaiser T, Walden M, Hillmann M, Wittke S, Herrmann A, Knueppel S, Haller H, Fliser D.
    Clin Sci (Lond); 2004 Nov; 107(5):485-95. PubMed ID: 15281910
    [Abstract] [Full Text] [Related]

  • 11. Proteomics and diabetic nephropathy.
    Merchant ML, Klein JB.
    Semin Nephrol; 2007 Nov; 27(6):627-36. PubMed ID: 18061845
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Glycosaminoglycans urinary excretion as a marker of the early stages of diabetic nephropathy and the disease progression.
    Popławska-Kita A, Mierzejewska-Iwanowska B, Szelachowska M, Siewko K, Nikołajuk A, Kinalska I, Górska M.
    Diabetes Metab Res Rev; 2008 Nov; 24(4):310-7. PubMed ID: 18273859
    [Abstract] [Full Text] [Related]

  • 16. Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus.
    Awadallah SM, Saleh SA, Abu Shaqra QM, Hilow H.
    J Diabetes Complications; 2008 Nov; 22(6):384-8. PubMed ID: 18413152
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Two-dimensional difference gel electrophoresis urinary proteomic profile in the search of nonimmune chronic allograft dysfunction biomarkers.
    Bañón-Maneus E, Diekmann F, Carrascal M, Quintana LF, Moya-Rull D, Bescós M, Ramírez-Bajo MJ, Rovira J, Gutierrez-Dalmau A, Solé-González A, Abián J, Campistol JM.
    Transplantation; 2010 Mar 15; 89(5):548-58. PubMed ID: 20134395
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A further investigation on a MALDI-based method for evaluation of markers of renal damage.
    Lapolla A, Molin L, Sechi A, Cosma C, Ragazzi E, Seraglia R, Traldi P.
    J Mass Spectrom; 2009 Dec 15; 44(12):1754-60. PubMed ID: 19852035
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.